Skip to content

The effect of L-citrulline on human cognitive function: a randomized, double-blind, parallel-group comparative study.

The effect of L-citrulline on human cognitive function: a randomized, double-blind, parallel-group comparative study. - The effect of L-citrulline on human cognitive function.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012887
Enrollment
45
Registered
2014-01-17
Start date
2014-01-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Sample and dose: L-citrulline 5600mg/day period: 8 days Sample and dose: L-citrulline 800mg/day and cellulose 4800mg/day period: 8 days Sample and dose: cellulose 5600mg/day (placebo) period: 8

Sponsors

C'est la vie Shinbashi Clinic, Medical Corporation Shinkokai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy and right-handed subjects. In female subjects, menopose occurred more than 6 months ago.

Exclusion criteria

Exclusion criteria: 1) regular medication for circulation system and central nerves system 2) history of psychiatric disorders or cerebrovascular diseases 3) serious liver, kidney, heart, respiratory, endocrine, or metabolic diseases 4) marked abnormal findings for blood and urine tests 5) smoker 6) heavy drinker of alcohol 7) obesity (BMI >= 30)

Design outcomes

Primary

MeasureTime frame
1) The changes in the oxy-Hb concentration and amplitudes and latencies of P300 of event-related potentials 2) Performance of the tasks 3) Psychological tests by using the visual analog scale (VAS)

Secondary

MeasureTime frame
1) vital signs (blood pressure and heart rate) 2) blood test (white blood cell count, red blood cell count, hemoglobin, hematocrit, and platelet count) 3) serum chemistry test (serum total protein, albumin, AST, ALT, LDH, gamma-GTP, urea nitrogen (UN), creatinine, uric acid (UA), sodium, chloride, potassium, total cholesterol, LDL cholesterol, HDL cholesterol, and blood glucose) 4) urinalysis (occult blood, urinary protein, urinary glucose, and urobilinogen)

Countries

Japan

Contacts

Public ContactYoshihiko Koga

Kyorin University School of Medicine Department of Neuropsychiatry

koga@ks.kyorin-u.ac.jp0422-47-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026